The special issue of the Journal of Clinical and Translational Science, “Re-engineering the Clinical Research Enterprise in Response to COVID-19: The CTSA Experience,” published in June 2021, highlights the Clinical and Translational Science Awards’ (CTSA) tremendous local, regional, and national response to the COVID-19 pandemic. This unique compendium of 14 articles demonstrates the CTSA Program in action, pivoting to address COVID-19’s particular challenge to our nation’s biomedical research enterprise with a multifaceted translational approach.
As part of the collection, the article "Challenges and Lessons Learned for Institutional Review Board Procedures During the COVID-19 Pandemic" delves into International Review Boards (IRB) meeting the need to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. UCLA CTSI associate director, Dr. Arash Naeim serves as lead author and UCLA CTSI director, Dr. Steven Dubinett, is a co-author.
This story was originally shared by CLIC-CTSA and has been adapted to include UCLA CTSI information.